PET imaging as a tool for assessing COVID-19 brain changes

dc.creatorFontana, Igor C.
dc.creatorBongarzone, Salvatore
dc.creatorGee, Antony
dc.creatorSouza, Diogo O.
dc.creatorZimmer, Eduardo R.
dc.date.accessioned2020-11-03T18:18:18Z
dc.date.available2020-11-03T18:18:18Z
dc.date.issued2020
dc.description.abstractA substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.pt_BR
dc.identifier.citationFONTANA, I. C. et al. PET imaging as a tool for assessing COVID-19 brain changes. Trends in Neurosciences, [S.l.], 2020. No prelo.pt_BR
dc.identifier.urihttps://repositorio.ufla.br/handle/1/43606
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0166223620302435pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsopenAccesspt_BR
dc.sourceTrends in Neurosciencespt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.subjectCOVID-19 - Neurological manifestationspt_BR
dc.subjectPositron Emission Tomography (PET) radiotracerspt_BR
dc.titlePET imaging as a tool for assessing COVID-19 brain changespt_BR
dc.typeArtigopt_BR

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
953 B
Formato:
Item-specific license agreed upon to submission
Descrição: